cefazolin (Q415739)

17 November 2015

Cefazolin.svg
512 × 190; 12 KB

0 references

mass

454.030014 dalton

1 reference

(6R,7S)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1-oxo-2-(1-tetrazolyl)ethyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

cefazolin (English)

4 October 2016

2 references

based on heuristic

inferred from InChIKey

based on heuristic

inferred from InChI

chemical formula

C₁₄H₁₄N₈O₄S₃

1 reference

cefazolin (English)

19 November 2016

CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O

1 reference

cefazolin (English)

19 November 2016

CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O

1 reference

parenteral route of administration

cefazolin (English)

19 November 2016

3 gram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=J01DB04

World Health Organisation international non-proprietary name

cefazolin (English)

1 reference

cefazolin (English)

medical condition treated

4 October 2016

Escherichia coli infectious disease

1 reference

upper respiratory tract infection

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

urinary tract infection

1 reference

13 December 2016

infective endocarditis

1 reference

gram-negative bacterial infection

13 December 2016

1 reference

13 December 2016

staphylococcal infection

2 references

13 December 2016

Drug Indications Extracted from FAERS

Food and Drug Administration

2 October 2018

Pseudomonas septicemia

start time

4 October 1973

approved by

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/IHS69L0Y4T

2 November 2018

reference URL

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=686cd696-0011-47b2-b342-142c20169ac6

pregnancy category

Australian pregnancy category B1

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category B

1 reference

imported from Wikimedia project

1 reference

https://www.pfizer.com/products/product-list

1 reference

5 March 2018

1 reference

Medical Subject Headings

15 March 2018

0 references

1 reference

‎WHO Aware Classification

access

1 reference

2023 ‎AWaRe classification‎

ceFAZolin

Institute for Safe Medication Practices

1 reference

reference URL

https://www.ismp.org/recommendations/tall-man-letters-list

2 September 2022

0 references

0 references

Cefazolin

0 references

Identifiers

National Library of Latvia ID

000337139

subject named as

Cefazolīns

0 references

InChI

InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1

1 reference

cefazolin (English)

19 November 2016

2 references

cefazolin (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

25953-19-9

2 references

cefazolin (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=25953-19-9

8 April 2021

1 reference

Cefazolin (English)

19 November 2016

2 references

cefazolin (English)

19 November 2016

Reaxys registry number

4169371

1 reference

cefazolin (English)

4 October 2016

mapping relation type

2 references

CEFAZOLIN (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1

1 reference

CEFAZOLIN (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU104501

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU104502

0 references

MSBNK-Athens_Univ-AU104503

0 references

MSBNK-Athens_Univ-AU104504

0 references

MSBNK-Athens_Univ-AU104505

0 references

MSBNK-Athens_Univ-AU104507

0 references

MSBNK-Athens_Univ-AU104508

0 references

MSBNK-Athens_Univ-AU104509

0 references

MSBNK-Athens_Univ-AU104510

0 references

MSBNK-Athens_Univ-AU104511

0 references

SPLASH

splash10-0aba-0943000000-da64d40a841f7fe440fe

0 references

splash10-0zfr-0910000000-f074c2d1d56b5f3da552

0 references

splash10-0q2i-0900000000-bbd7d226d641cfe51521

0 references

splash10-0l1r-0900000000-18addd569fa36108660e

0 references

HSDB ID

3213

1 reference

Hazardous Substances Data Bank

28 October 2019

CEFAZOLIN (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

1 reference

cefazolin (English)

ECHA Substance Infocard ID

19 November 2016

100.043.042

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Cefazolin (English)

CAS no.: 25953-19-9 (English)

1 reference

Guide to Pharmacology Ligand ID

Cefazolin (English)

publication date

17 November 2015

10935

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

Cefazolin

0 references

MeSH concept ID

M0003718

0 references

MeSH tree code

D02.065.589.099.249.160

0 references

D02.886.665.074.160

0 references

D03.633.100.300.249.160

0 references

RxNorm ID

2180

1 reference

cefazolin (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0015422

2 references

based on heuristic

inferred from InChIKey

2 references

cefazolin (English)

19 November 2016

MedlinePlus drug identifier

a682731

0 references

PatientsLikeMe treatment ID

0 references

1 reference

cefazolin (English)

19 November 2016

0 references

1 reference

1 reference

Immune Epitope Database and Analysis Resource

cefazolin (English)

4 October 2016

1 reference

1 March 2022

1 reference

6 April 2020

0 references

electronic Essential Medicines List medicine ID

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

Römpp online ID

RD-03-00782

1 reference

imported from Wikimedia project

1 reference